Impact of tumor hypoxia and anemia on radiation therapy outcomes.
about
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationOvercoming the hypoxic barrier to radiation therapy with anaerobic bacteriaThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesPositron emission tomography to assess hypoxia and perfusion in lung cancerHigh and low dose radiation effects on mammary adenocarcinoma cells - an epigenetic connectionHemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy.Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapyLaboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyInteraction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer.A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinomaIncidence and risk factors for infection in oral cancer patients undergoing different treatments protocolsAssociation between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers.Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.Impact of preoperative anemia on relapse and survival in breast cancer patients.Reducing X-Ray Induced Oxidative Damages in Fibroblasts with Graphene Oxide.Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.Applications of molecular imaging.Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based StudySignificant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).Imaging virus-associated cancer.The impact of anaemia on outcome in cancer.68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat StudiesEffect of Heat-Inactivated Clostridium sporogenes and Its Conditioned Media on 3-Dimensional Colorectal Cancer Cell ModelsTAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy.Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in MiceQuantitative assessment of tumor responses after radiation therapy in a DLD-1 colon cancer mouse model using serial dynamic contrast-enhanced magnetic resonance imagingMicroenvironments and cellular characteristics in the micro tumor cords of malignant solid tumorsSulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin.Nanomedicine in chemoradiation.Pancreatic cancer: why is it so hard to treat?Effects of ectopic expression of NGAL on doxorubicin sensitivity.Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficientsDecreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2).Copper-64 Radiopharmaceuticals for Oncologic Imaging
P2860
Q21133512-C941CD0F-8C03-46CE-8357-CC4063E54A6BQ24569648-6E560426-0C5A-4DDF-952C-CECA988E0922Q27025579-F88A1076-DBBE-42BE-ADDE-8045A7D90EBBQ27026940-BB1E089B-3635-495F-8A4C-ADC5FE21F5F8Q28394677-4C3EA875-1C79-4505-B309-4B33B1B8080DQ30524018-305A9171-35D6-4A47-A21B-7AC6F7C0C049Q33731187-8E20A869-E7B7-4C83-8BE0-758F92059EDCQ33834316-9E1D5438-CC52-4228-AD08-38DBDC5FA9E5Q33834772-6B72A4AD-6827-4AFE-8197-79ABB67142ADQ33985206-1A95FEF9-F0C5-464D-B0DB-C28CF96E412BQ34019720-B63153EB-1793-49F9-B1DB-68487174174DQ34346429-3486D6F0-61C5-4B2B-A269-C008FCF49159Q34377675-093F81A3-EB27-4D9B-AE22-3E3F069D2655Q34407938-74DC54A7-FFC8-4F23-B20A-3A84D702D78EQ34494886-DBE29DDA-C10A-4368-BD22-AB940CD94325Q34565736-56D24FA4-9457-4595-A01D-204B58EFB721Q34724034-F7E27869-E755-46BB-9C55-AE5ED4A8B83BQ35004509-0B3ED88C-1839-465C-B32E-5356BCD72D2EQ35048388-4293D191-B8A6-45AE-9036-BC8F84F2FD27Q35082412-028EADA6-4590-4D56-80A5-674F8F8CAC8EQ35648863-19BD2932-C9A4-41BE-80C5-CB3A2D78A295Q35751128-B2FDB41F-9B70-45EF-AE9F-F39E8B5BFA1DQ35769008-BDC65566-8B1B-42E2-A179-A70B52854822Q36015054-A25374AF-BDB0-433E-A126-730940AF7251Q36027331-122D837A-BFB7-4C2A-9465-6DDE1A5262E9Q36163785-E78783AC-7905-44FF-9FA2-5B9F438FA8B1Q36216216-17053A86-AD29-4949-AE62-8F39B4F027EFQ36232062-0F1F291C-5DED-4EDF-9054-3884088AABB3Q36335266-0020B378-036B-4992-A2B6-0AEB009181EBQ36347971-DB829D0D-F9D5-40BA-A311-994C355B43C2Q36432405-703F7486-2E6D-4672-8E65-B557F047EF5AQ36546587-71410ED8-4373-4848-A768-1F0834650285Q36696163-EF8DC5C0-8B72-4D5F-BF7F-1B6EFAA41C34Q36779858-3C842771-63DA-4F35-897A-7AC1176E3D72Q36838995-8C7D7914-D3A1-48FD-970B-1D2E2625357DQ36886497-7E828B14-5492-467C-9A18-70F38B288A36Q37031268-BA7E9C44-031D-4F02-BC79-4499E3075A46Q37050416-D47DFCEA-B0A4-4402-9C4C-07BFC9F33F04Q37067244-A8E34F58-32A8-4128-87BA-AEF94586219EQ37126530-F5D714A7-A2BC-4E40-B26E-918E5899F81E
P2860
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@ast
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@en
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@nl
type
label
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@ast
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@en
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@nl
prefLabel
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@ast
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@en
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@nl
P2093
P1433
P1476
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
@en
P2093
Kenneth Hu
Louis B Harrison
Manjeet Chadha
Richard J Hill
P304
P356
10.1634/THEONCOLOGIST.7-6-492
P577
2002-01-01T00:00:00Z